Last updated on July 2017

Study of VIS410 in Subjects With Uncomplicated Influenza A

Brief description of study

This is a Phase 2a randomized, double-blind, placebo-controlled study designed to assess the safety and tolerability of VIS410 in subjects with uncomplicated influenza.

Detailed Study Description

Subjects will be admitted to an infusion unit for drug administration and observation following infusion. The study is designed to compare an infusion of a single high or low IV dose of VIS410 against placebo. Subjects will be followed for 100 (±7 days).

Clinical Study Identifier: NCT02989194

Find a site near you

Start Over

Visterra Inc

Nis, Serbia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.